HDL - Cholesterol: The New Target for Treatment

Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal, Ashraf Ganie

Journal Name: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Volume 4 , Issue 2 , 2010


In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.

Keywords: HDL cholesterol, hyperlipidemia, niacin, fibrates, statins

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [153 - 160]
Pages: 8
DOI: 10.2174/187221410791196605
Price: $58

Article Metrics

PDF: 6